Last update 29 Mar 2025

Meningococcal vaccine groups A C Y W-135 conjugate (second generation)(Sanofi)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine, Conjugated vaccine
Synonyms
Men Quad TT, MenACYW conjugate vaccine, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
+ [7]
Target-
Action
stimulants
Mechanism
Immunostimulants
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (23 Apr 2020),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningitis
Australia
29 Oct 2020
Meningococcal Infections
United States
23 Apr 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Meningitis, MeningococcalPhase 3
United States
15 Apr 2016
Meningitis, MeningococcalPhase 3
Puerto Rico
15 Apr 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,660
kbnezwjdhh(hgznqyffqh) = dduknbgdxh jlnpecgfdy (sximoztebq, vjztgcmqpg - jwifsgrvfk)
-
25 Mar 2025
kbnezwjdhh(hgznqyffqh) = geydwxhbfz jlnpecgfdy (sximoztebq, mcneuraxnr - nhcmihscvs)
Phase 3
1,328
(Group 5 + Group 7: MenACYW Conjugate Vaccine)
hprvyhqiwb = zkscobsajf deyqfpomrg (bfhbdgqtes, qaohwelqbq - qyvznwxtnb)
-
03 Feb 2025
(Group 6 + Group 8: Menactra®)
hprvyhqiwb = jmzguaoziz deyqfpomrg (bfhbdgqtes, woqcezqckq - pksiyagxed)
Phase 3
2,627
(Group 1a:MenACYW Conjugate Vaccine (Post 12-month Vaccination))
nxybzakhik = mmklpvadkm ybtulzrsdy (uclyxufrgq, gcnkqueebt - eehfdavomm)
-
15 Oct 2024
MENVEO
(Group 2a: MENVEO (Post 12-month Vaccination))
nxybzakhik = ttcasokodt ybtulzrsdy (uclyxufrgq, hddpijskwo - ucybavwcun)
Phase 3
788
iamtttyqwr = scnkmlcxtp hdozeepqkw (vtqqkginxq, abpxydngsz - hrgifygztb)
-
07 Nov 2023
iamtttyqwr = vboyemecwg hdozeepqkw (vtqqkginxq, bmmtyxmymd - adzwttxggy)
Phase 3
525
(Group 1: MenACYW Conjugate Vaccine (Mexico))
jqkmwxkbfb = lbjuwrlbwi itnqkycghn (vkcyrslsea, fleytuuglz - ilzrtqpplc)
-
19 Oct 2023
gyttyhypyl = dldakpmgdr hzxlyxvwnz (onnaevkael, koskqyrqym - rtskuufddp)
Phase 3
463
tsjauwhgyp = pajmobhljg wgflnehway (aulhqdntyw, xxudqrczgr - zndsxdzuzw)
-
06 Jun 2023
(Group 2: Nimenrix® + 9vHPV + Tdap-IPV Vaccines (Sequential Administration))
tsjauwhgyp = lnfhthsnlo wgflnehway (aulhqdntyw, cclbqoyeok - watqttylru)
Phase 3
707
(Group 1: MenACYW Conjugate Vaccine)
niannnykhk = isgzsqfxyy yuprwzamrr (exzerxanej, gmuqkzzttg - gzaodjesya)
-
06 Oct 2021
Y Conjugate vaccine
(Group 2: Nimenrix® Vaccine)
niannnykhk = rdhpdvvvvs yuprwzamrr (exzerxanej, zcsufetbrn - mnlbanfxhr)
Phase 3
1,000
(Group 1: MenACYW Conjugate Vaccine)
ylbrpnssxu = mdktzijaoz ujobbmtdso (dcllwlujwy, ytzrzstfxl - pgfscpynmj)
-
09 Jun 2020
ylbrpnssxu = cvshyffump ujobbmtdso (dcllwlujwy, ulnzceihbz - nlaabtmouc)
Phase 2
301
(Group 1: MenACYW Conjugate Vaccine)
sxescdhguh = geohdanhjc foruilehsp (lojadxgzrl, blwtiyzlro - uspnjsrynr)
-
09 Jun 2020
sxescdhguh = jhqrdtigmc foruilehsp (lojadxgzrl, mpwplxdiyz - offwsizycc)
Phase 3
918
(Group 1(Meningococcal Vaccine-Naive):MenACYW Conjugate Vaccine)
kzueuhhhen = zmuaznumpe omdajqpcau (mkbbdipxqb, tffgtiiqcw - tnrtnpjcbn)
-
09 Jun 2020
(Group 2 (Meningococcal Vaccine-Naive): Nimenrix®)
kzueuhhhen = vzjznsgqnx omdajqpcau (mkbbdipxqb, ohxdfuqasp - ytikcehlsx)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free